Cargando…

Endogenous calcitonin gene-related peptide in cerebrospinal fluid and early quality of life and mental health after good-grade spontaneous subarachnoid hemorrhage—a feasibility series

The vasodilatory calcitonin gene-related peptide (CGRP) is excessively released after spontaneous subarachnoid hemorrhage (sSAH) and modulates psycho-behavioral function. In this pilot study, we prospectively analyzed the treatment-specific differences in the secretion of endogenous CGRP into cerebr...

Descripción completa

Detalles Bibliográficos
Autores principales: Bründl, Elisabeth, Proescholdt, Martin, Störr, Eva-Maria, Schödel, Petra, Bele, Sylvia, Höhne, Julius, Zeman, Florian, Brawanski, Alexander, Schebesch, Karl-Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8121729/
https://www.ncbi.nlm.nih.gov/pubmed/32572710
http://dx.doi.org/10.1007/s10143-020-01333-z
_version_ 1783692431268511744
author Bründl, Elisabeth
Proescholdt, Martin
Störr, Eva-Maria
Schödel, Petra
Bele, Sylvia
Höhne, Julius
Zeman, Florian
Brawanski, Alexander
Schebesch, Karl-Michael
author_facet Bründl, Elisabeth
Proescholdt, Martin
Störr, Eva-Maria
Schödel, Petra
Bele, Sylvia
Höhne, Julius
Zeman, Florian
Brawanski, Alexander
Schebesch, Karl-Michael
author_sort Bründl, Elisabeth
collection PubMed
description The vasodilatory calcitonin gene-related peptide (CGRP) is excessively released after spontaneous subarachnoid hemorrhage (sSAH) and modulates psycho-behavioral function. In this pilot study, we prospectively analyzed the treatment-specific differences in the secretion of endogenous CGRP into cerebrospinal fluid (CSF) during the acute stage after good-grade sSAH and its impact on self-reported health-related quality of life (hrQoL). Twenty-six consecutive patients (f:m = 13:8; mean age 50.6 years) with good-grade sSAH were enrolled (drop out 19% (n = 5)): 35% (n = 9) underwent endovascular aneurysm occlusion, 23% (n = 6) microsurgery, and 23% (n = 6) of the patients with perimesencephalic SAH received standardized intensive medical care. An external ventricular drain was inserted within 72 h after the onset of bleeding. CSF was drawn daily from day 1–10. CGRP levels were determined via competitive enzyme immunoassay and calculated as “area under the curve” (AUC). All patients underwent a hrQoL self-report assessment (36-Item Short Form Health Survey (SF-36), ICD-10-Symptom-Rating questionnaire (ISR)) after the onset of sSAH (t(1): day 11–35) and at the 6-month follow-up (t(2)). AUC CGRP (total mean ± SD, 5.7 ± 1.8 ng/ml/24 h) was excessively released into CSF after sSAH. AUC CGRP levels did not differ significantly when dichotomizing the aSAH (5.63 ± 1.77) and pSAH group (5.68 ± 2.08). aSAH patients revealed a higher symptom burden in the ISR supplementary item score (p = 0.021). Multiple logistic regression analyses corroborated increased mean levels of AUC CGRP in CSF at t(1) as an independent prognostic factor for a significantly higher symptom burden in most ISR scores (compulsive-obsessive syndrome (OR 5.741, p = 0.018), anxiety (OR 7.748, p = 0.021), depression (OR 2.740, p = 0.005), the supplementary items (OR 2.392, p = 0.004)) and for a poorer performance in the SF-36 physical component summary score (OR 0.177, p = 0.001). In contrast, at t(2), CSF AUC CGRP concentrations no longer correlated with hrQoL. To the best of our knowledge, this study is the first to correlate the levels of endogenous CSF CGRP with hrQoL outcome in good-grade sSAH patients. Excessive CGRP release into CSF may have a negative short-term impact on hrQoL and emotional health like anxiety and depression. While subacutely after sSAH, higher CSF levels of the vasodilator CGRP are supposed to be protective against vasospasm-associated cerebral ischemia, from a psychopathological point of view, our results suggest an involvement of CSF CGRP in the dysregulation of higher integrated behavior.
format Online
Article
Text
id pubmed-8121729
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-81217292021-05-18 Endogenous calcitonin gene-related peptide in cerebrospinal fluid and early quality of life and mental health after good-grade spontaneous subarachnoid hemorrhage—a feasibility series Bründl, Elisabeth Proescholdt, Martin Störr, Eva-Maria Schödel, Petra Bele, Sylvia Höhne, Julius Zeman, Florian Brawanski, Alexander Schebesch, Karl-Michael Neurosurg Rev Original Article The vasodilatory calcitonin gene-related peptide (CGRP) is excessively released after spontaneous subarachnoid hemorrhage (sSAH) and modulates psycho-behavioral function. In this pilot study, we prospectively analyzed the treatment-specific differences in the secretion of endogenous CGRP into cerebrospinal fluid (CSF) during the acute stage after good-grade sSAH and its impact on self-reported health-related quality of life (hrQoL). Twenty-six consecutive patients (f:m = 13:8; mean age 50.6 years) with good-grade sSAH were enrolled (drop out 19% (n = 5)): 35% (n = 9) underwent endovascular aneurysm occlusion, 23% (n = 6) microsurgery, and 23% (n = 6) of the patients with perimesencephalic SAH received standardized intensive medical care. An external ventricular drain was inserted within 72 h after the onset of bleeding. CSF was drawn daily from day 1–10. CGRP levels were determined via competitive enzyme immunoassay and calculated as “area under the curve” (AUC). All patients underwent a hrQoL self-report assessment (36-Item Short Form Health Survey (SF-36), ICD-10-Symptom-Rating questionnaire (ISR)) after the onset of sSAH (t(1): day 11–35) and at the 6-month follow-up (t(2)). AUC CGRP (total mean ± SD, 5.7 ± 1.8 ng/ml/24 h) was excessively released into CSF after sSAH. AUC CGRP levels did not differ significantly when dichotomizing the aSAH (5.63 ± 1.77) and pSAH group (5.68 ± 2.08). aSAH patients revealed a higher symptom burden in the ISR supplementary item score (p = 0.021). Multiple logistic regression analyses corroborated increased mean levels of AUC CGRP in CSF at t(1) as an independent prognostic factor for a significantly higher symptom burden in most ISR scores (compulsive-obsessive syndrome (OR 5.741, p = 0.018), anxiety (OR 7.748, p = 0.021), depression (OR 2.740, p = 0.005), the supplementary items (OR 2.392, p = 0.004)) and for a poorer performance in the SF-36 physical component summary score (OR 0.177, p = 0.001). In contrast, at t(2), CSF AUC CGRP concentrations no longer correlated with hrQoL. To the best of our knowledge, this study is the first to correlate the levels of endogenous CSF CGRP with hrQoL outcome in good-grade sSAH patients. Excessive CGRP release into CSF may have a negative short-term impact on hrQoL and emotional health like anxiety and depression. While subacutely after sSAH, higher CSF levels of the vasodilator CGRP are supposed to be protective against vasospasm-associated cerebral ischemia, from a psychopathological point of view, our results suggest an involvement of CSF CGRP in the dysregulation of higher integrated behavior. Springer Berlin Heidelberg 2020-06-22 2021 /pmc/articles/PMC8121729/ /pubmed/32572710 http://dx.doi.org/10.1007/s10143-020-01333-z Text en © The Author(s) 2020 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Article
Bründl, Elisabeth
Proescholdt, Martin
Störr, Eva-Maria
Schödel, Petra
Bele, Sylvia
Höhne, Julius
Zeman, Florian
Brawanski, Alexander
Schebesch, Karl-Michael
Endogenous calcitonin gene-related peptide in cerebrospinal fluid and early quality of life and mental health after good-grade spontaneous subarachnoid hemorrhage—a feasibility series
title Endogenous calcitonin gene-related peptide in cerebrospinal fluid and early quality of life and mental health after good-grade spontaneous subarachnoid hemorrhage—a feasibility series
title_full Endogenous calcitonin gene-related peptide in cerebrospinal fluid and early quality of life and mental health after good-grade spontaneous subarachnoid hemorrhage—a feasibility series
title_fullStr Endogenous calcitonin gene-related peptide in cerebrospinal fluid and early quality of life and mental health after good-grade spontaneous subarachnoid hemorrhage—a feasibility series
title_full_unstemmed Endogenous calcitonin gene-related peptide in cerebrospinal fluid and early quality of life and mental health after good-grade spontaneous subarachnoid hemorrhage—a feasibility series
title_short Endogenous calcitonin gene-related peptide in cerebrospinal fluid and early quality of life and mental health after good-grade spontaneous subarachnoid hemorrhage—a feasibility series
title_sort endogenous calcitonin gene-related peptide in cerebrospinal fluid and early quality of life and mental health after good-grade spontaneous subarachnoid hemorrhage—a feasibility series
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8121729/
https://www.ncbi.nlm.nih.gov/pubmed/32572710
http://dx.doi.org/10.1007/s10143-020-01333-z
work_keys_str_mv AT brundlelisabeth endogenouscalcitoningenerelatedpeptideincerebrospinalfluidandearlyqualityoflifeandmentalhealthaftergoodgradespontaneoussubarachnoidhemorrhageafeasibilityseries
AT proescholdtmartin endogenouscalcitoningenerelatedpeptideincerebrospinalfluidandearlyqualityoflifeandmentalhealthaftergoodgradespontaneoussubarachnoidhemorrhageafeasibilityseries
AT storrevamaria endogenouscalcitoningenerelatedpeptideincerebrospinalfluidandearlyqualityoflifeandmentalhealthaftergoodgradespontaneoussubarachnoidhemorrhageafeasibilityseries
AT schodelpetra endogenouscalcitoningenerelatedpeptideincerebrospinalfluidandearlyqualityoflifeandmentalhealthaftergoodgradespontaneoussubarachnoidhemorrhageafeasibilityseries
AT belesylvia endogenouscalcitoningenerelatedpeptideincerebrospinalfluidandearlyqualityoflifeandmentalhealthaftergoodgradespontaneoussubarachnoidhemorrhageafeasibilityseries
AT hohnejulius endogenouscalcitoningenerelatedpeptideincerebrospinalfluidandearlyqualityoflifeandmentalhealthaftergoodgradespontaneoussubarachnoidhemorrhageafeasibilityseries
AT zemanflorian endogenouscalcitoningenerelatedpeptideincerebrospinalfluidandearlyqualityoflifeandmentalhealthaftergoodgradespontaneoussubarachnoidhemorrhageafeasibilityseries
AT brawanskialexander endogenouscalcitoningenerelatedpeptideincerebrospinalfluidandearlyqualityoflifeandmentalhealthaftergoodgradespontaneoussubarachnoidhemorrhageafeasibilityseries
AT schebeschkarlmichael endogenouscalcitoningenerelatedpeptideincerebrospinalfluidandearlyqualityoflifeandmentalhealthaftergoodgradespontaneoussubarachnoidhemorrhageafeasibilityseries